Biomarkers of Neurological Disorders
Reference181 articles.
1. Abdi F, Quinn JF, Jankovic J, et al. Detection of Biomarkers with a Multiplex Quantitative Proteomic Platform in Cerebrospinal Fluid of Patients with Neurodegenerative Disorders. JAD 2006;9:293–348.
2. Ahlers C, Golbaz I, Einwallner E, et al. Identification of optical density ratios in subretinal fluid as a clinically relevant biomarker in exudative macular disease. Invest Ophthalmol Vis Sci 2009;50:3417–24.
3. Akuffo EL, Davis JB, Fox SM, et al. The discovery and early validation of novel plasma biomarkers in mild-to-moderate Alzheimer’s disease patients responding to treatment with rosiglitazone. Biomarkers 2008;13:618–36.
4. Allard L, Burkhard PR, Lescuyer P, et al. PARK7 and nucleoside diphosphate kinase A as plasma markers for the early diagnosis of stroke. Clin Chem 2005;51:2043–51.
5. Allard L, Lescuyer P, Burgess J, et al. ApoC-I and ApoCIII as potential plasmatic markers to distinguish between ischemic and hemorrhagic stroke. Proteomics 2004;4:2242–51.